Burn, John <br/><br/>
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.  [electronic resource] 

 -  Lancet (London, England)  Dec 2011 
 - 2081-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1474-547X 
<br/><br/><label>Standard No.: </label>10.1016/S0140-6736(11)61049-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoma--prevention & control<br/>Anti-Inflammatory Agents, Non-Steroidal--therapeutic use<br/>Aspirin--therapeutic use<br/>Chemoprevention<br/>Colorectal Neoplasms, Hereditary Nonpolyposis--genetics<br/>Dietary Carbohydrates--therapeutic use<br/>Double-Blind Method<br/>Heterozygote<br/>Humans<br/>Starch--therapeutic use